United Capital Financial Advisors’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Sell
5,914
-6,418
-52% -$347K ﹤0.01% 1208
2026
Q1
$644K Buy
12,332
+4,745
+63% +$285K ﹤0.01% 945
2025
Q4
$446K Sell
7,587
-132
-2% -$8.02K ﹤0.01% 1010
2025
Q3
$429K Sell
7,719
-512
-6% -$27.4K ﹤0.01% 905
2025
Q2
$423K Buy
8,231
+3,686
+81% +$185K ﹤0.01% 821
2025
Q1
$266K Buy
4,545
+73
+2% +$4.95K ﹤0.01% 927
2024
Q4
$322K Buy
4,472
+78
+2% +$5.73K ﹤0.01% 860
2024
Q3
$351K Buy
4,394
+190
+5% +$14.3K ﹤0.01% 827
2024
Q2
$301K Sell
4,204
-173
-4% -$12.7K ﹤0.01% 849
2024
Q1
$308K Sell
4,377
-23
-0.5% -$1.65K ﹤0.01% 866
2023
Q4
$340K Buy
+4,400
New +$290K ﹤0.01% 828

Other funds holding TECH

United Capital Financial Advisors's TECH Position: Q2 2026 in Review

United Capital Financial Advisors reduced its Bio-Techne (TECH) stake by 52% in Q2 2026, selling an estimated $347K and leaving 5,914 shares worth $418K. The position accounts for ﹤0.01% of the portfolio, ranked #1208.

United Capital Financial Advisors first reported a position in TECH in Q4 2023 and has held it in 11 quarters since. The position peaked at $644K in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • United Capital Financial Advisors held 5,914 shares of Bio-Techne worth $418K as of Q2 2026.
  • United Capital Financial Advisors sold 6,418 Bio-Techne shares in Q2 2026, an estimated $347K.
  • Bio-Techne made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #1208 holding.
  • United Capital Financial Advisors first reported a position in Bio-Techne in Q4 2023 and has held it in 11 quarters since.
  • United Capital Financial Advisors's Bio-Techne position peaked at $644K in Q1 2026.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.